Author
Eri Kato
Also Known As
Chakraborty, E KATO, E Kato, E Kato Jr, E. T. Kato, ERI T. KATO, Eri KATO, Eri Kato, Eri T Kato, Eri T. Kato
97
Publications
12.4K
Citations
21
H-Index
44
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 11 | 11 | 1.2K |
2 | Public Health | 4 | 4 | 152 |
3 | Diabetes | 2 | 2 | 689 |
4 | Epidemiology | 2 | 2 | 51 |
5 | Gastroenterology | 1 | 1 | 35 |
Eri Kato
×
27
Publications
8.6K
Citations
19
H-Index
| Year | Citations | |
|---|---|---|
2018 | 6K | |
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn, The Lancet Diabetes & Endocrinology Metabolic SyndromeDeclare–timi 58Diabetes ManagementRenal DiseaseChronic Kidney Disease | 2019 | 656 |
2019 | 550 | |
2016 | 275 | |
2018 | 179 | |
2017 | 141 | |
2018 | 108 | |
2025 | 98 | |
2021 | 89 | |
2017 | 71 |
Page 1
Page 1